Patient perceptions of insulin therapy in diabetes self-management with insulin injection devices

AimsSeveral insulin delivery systems are available to control glycemia in patients with diabetes. Recently introduced devices feature connectivity enabling data transfer to smartphone applications to provide decision support and reduce errors in dosing and timing, while reducing the cognitive burden.MethodsWe conducted an online survey in Italian patients with a self-reported diagnosis of diabetes to assess patient perceptions of insulin therapy management, and their impressions of connection-enabled insulin pens compared to standard insulin pens. The Morisky Medication Adherence Scale-8 was used to assess adherence to insulin therapy.ResultsAmong 223 respondents (108 with type 1 diabetes; 115 with type 2 diabetes), the most prominent unmet need was the necessity to overcome the cognitive burden of care associated with measuring, calculating, timing, and recording therapy. Only 25% of respondents had high adherence; 28% had low adherence.ConclusionsWhen asked to compare the attributes of a non-connected insulin pen with those of a new connected device, 71% of patients rated the new proposal very useful. The cognitive burden associated with self-management of diabetes therapy may influence preferences for advanced insulin delivery systems.

Automated summary

This study aimed to evaluate patient perceptions of insulin therapy management and their impressions of connected insulin pens compared to standard insulin pens. Findings showed that patients had a high need to overcome the cognitive burden associated with insulin therapy, and only 25% of patients had high adherence. Patients rated connected insulin pens as very useful, suggesting that reducing the cognitive burden can influence preferences for insulin delivery systems.